ID   KKU-M214/246
SY   M214/246
DR   Wikidata; Q114311820
RX   PubMed=18714155;
CC   Problematic cell line: Contaminated. Parent cell line (KKU-213B) shown to be a KKU-M213 derivative.
CC   Population: Southeast Asian; Thai.
CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gly13Cys (c.37G>T); ClinVar=VCV000045123; Zygosity=Unspecified (from parent cell line).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   NCIt; C27769; Opisthorchis viverrini-related cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_M264 ! KKU-213B
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
RX   PubMed=18714155; DOI=10.1159/000151541;
RA   Namwat N., Amimanan P., Loilome W., Jearanaikoon P., Sripa B.,
RA   Bhudhisawasdi V., Tassaneeyakul W.;
RT   "Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell
RT   lines.";
RL   Chemotherapy 54:343-351(2008).